久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • CTI, Servier’s Pixuvri fails in post-marketing trial pharmatimes
    July 16, 2018
    A late-stage trial of Servier and CTI BioPharma’s Pixuvri in combination with Roche's MabThera has failed to hit targets in B-cell non-Hodgkin lymphoma, putting its conditional approval in Europe in jeopardy.
  • CTI BioPharma Appoints Director contractpharma
    July 25, 2017
    Dr. Fischer brings 20 years of experience in developing and commercializing biopharmaceuticals
PharmaSources Customer Service